Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.
Authors
Fotouhi, OKjellin, H
Larsson, C
Hashemi, J
Barriuso, J
Juhlin, C
Lu, M
Höög, A
Pastrián, L
Lamarca, Angela
Soto, V
Zedenius, J
Mendiola, M
Lehtiö, J
Kjellman, M
Affiliation
Department of Oncology-Pathology Karolinska Institutet, StockholmIssue Date
2016-10
Metadata
Show full item recordAbstract
Somatostatin analogs are established in the treatment of neuroendocrine tumors (NETs) including small intestinal NET; however, the molecular mechanisms are not well known. Here, we examined the direct effects of lanreotide in NET cell line models.Citation
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. 2016, 101 (10):3616-3627 J Clin Endocrinol MetabJournal
The Journal of Clinical Endocrinology and MetabolismDOI
10.1210/jc.2016-2028PubMed ID
27459532Type
ArticleLanguage
enISSN
1945-7197ae974a485f413a2113503eed53cd6c53
10.1210/jc.2016-2028